The Preventable Productivity Burden of Kidney Disease in Australia
- 9 March 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 32 (4) , 938-949
Abstract
Significance Statement: Kidney disease is associated with reduced work productivity. The authors describe the preventable productivity burden of kidney disease in Australia over 10 years (2020–2029), using the novel metric “productivity-adjusted life year” (PALY). The PALY resembles the quality-adjusted life year, but it adjusts years of life lived for productivity loss resulting from ill health instead of quality-of-life impairment. They demonstrate that, if 10% of future cases of kidney disease can be prevented over this period, >7500 PALYs could be saved, equivalent to a gain of US$1.1 billion in gross domestic product. These results have potential to inform policy makers regarding the need and the substantial financial incentive for the prevention of kidney disease. Background: Kidney disease is associated with impaired work productivity. However, the collective effect of missed work days, reduced output at work, and early withdrawal from the workforce is rarely considered in health-economic evaluations. Methods: To determine the effect on work productivity of preventing incident cases of kidney disease, using the novel measure “productivity-adjusted life year” (PALY), we constructed a dynamic life table model for the Australian working-age population (aged 15–69 years) over 10 years (2020–2029), stratified by kidney-disease status. Input data, including productivity estimates, were sourced from the literature. We ascribed a financial value to the PALY metric in terms of gross domestic product (GDP) per equivalent full-time worker and assessed the total number of years lived, total PALYs, and broader economic costs (GDP per PALY). We repeated the model simulation, assuming a reduced kidney-disease incidence; the differences reflected the effects of preventing new kidney-disease cases. Outcomes were discounted by 5% annually. Results: Our projections indicate that, from 2020 to 2029, the estimated number of new kidney-disease cases will exceed 161,000. Preventing 10% of new cases of kidney disease during this period would result in >300 premature deaths averted and approximately 550 years of life and 7600 PALYs saved—equivalent to a savings of US$1.1 billion in GDP or US$67,000 per new case avoided. Conclusions: Pursuing a relatively modest target for preventing kidney disease in Australia may prolong years of life lived and increase productive life years, resulting in substantial economic benefit. Our findings highlight the need for investment in preventive measures to reduce future cases of kidney disease.Keywords
This publication has 34 references indexed in Scilit:
- Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort studyBMJ Open, 2014
- Lifetime Incidence of CKD Stages 3-5 in the United StatesAmerican Journal of Kidney Diseases, 2013
- Employment of Patients Receiving Maintenance Dialysis and After Kidney Transplant: A Cross-sectional Study From FinlandAmerican Journal of Kidney Diseases, 2012
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesKidney International, 2011
- Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study)Nephrology Dialysis Transplantation, 2011
- Association of CKD With Disability in the United StatesAmerican Journal of Kidney Diseases, 2011
- Cost Implications of Caring for Chronic Kidney Disease: Are Interventions Cost-effective?Advances in Chronic Kidney Disease, 2010
- The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and ageKidney International, 2006
- Lost Productive Work Time Costs From Health Conditions in the United States: Results From the American Productivity AuditJournal of Occupational and Environmental Medicine, 2003
- Utilities and Quality-Adjusted Life YearsInternational Journal of Technology Assessment in Health Care, 1989